Events
Nanoparticles in Therapeutic Innovation
Friday 19 September 2025 - Amsterdam
Thrilled to have joined the 6th MELOMANES MSCA project meeting in Amsterdam at Athena Research and Education Institute. These meetings provide a valuable platform to deepen collaborations and foster dynamic exchanges of perspectives.
We have the chance to benefit from the collective expertise of all partners. We’re inspired by the remarkable progress achieved so far and to look forward with confidence to the next steps of this collaborative journey!
We were delighted to attend the 2025 Innovative Therapies Days, a landmark event connecting academia and industry, from research and proof of concept to clinical and industrial translation. By offering an exceptional insight into the evolving landscape of advanced therapeutic development, highlighting breakthroughs in cell and gene therapies, CAR-T innovation, and particularly the emerging role of extracellular vesicles (EVs) as next-generation therapeutic platforms, these perspectives align with Exosiris’s mission to drive precise, personalized treatments for unmet clinical needs.
Exosiris was present at the PSCC Innovation Forum 2026
February 4th 2026 - Villejuif
We were proud to be present at the PSCC Innovation Forum 2026, where more than 700 participants gathered on World Cancer Day to advance innovation in oncology. The event brought together entrepreneurs, researchers, investors, industry leaders, large companies, patients, and patient associations, highlighting the strength and collaboration of the oncology ecosystem. With 30 world-class speakers, over 650 B2B meetings, and inspiring startup pitches, the forum showcased cutting-edge breakthroughs and the collective momentum driving the future of cancer innovation.
MELOMANES Consortium Meeting & Training Sessions
March 16th to 20th 2026 - in Cambridge
International Symposium: Innovative Therapies Days
October 9th & 10th, 2025 - Kursaal Besançon
We are particularly proud to collaborate with a leading organization in the field of mRNA-based therapies, reflecting the strength of a rapidly growing innovation ecosystem dedicated to advancing next-generation healthcare. We are honored to contribute, at its own scale, to the progress of groundbreaking therapeutic approaches that have the potential to transform patient care.
Coming Soon: Exosiris at the 14th AIS Conference
June 30th- July 1st 2026 - in Montpellier
France BioLead 2026: Exosiris contributes to shaping the future of CAR-T therapies in France
June 2nd 2026 - in Paris
Congratulations InTheRNA on Its New Milestone
June 19th 2026 - in Orleans
See You at the French Tech Night – Exosiris Is Joining the Conversation
June 25th 2026 - in Bordeaux
We are proud to have attended and actively participated in the national workshop organized by France BioLead and UNITC, bringing together leading stakeholders from academia, hospitals, biotech companies, manufacturers, and public institutions to define a common roadmap for the development of CAR in vivo therapies in France.
Newsletter
Stay updated on groundbreaking nanomedicine advancements.